Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach

Davide Tassinari,Sergio Sartori,M. Papi,Fabrizio Drudi,Cinzia Castellani,Federica Carloni,Paola Tombesi,Luigi Lazzari-Agli

Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach

2011

Davide Tassinari
Sergio Sartori
M. Papi
Fabrizio Drudi
Cinzia Castellani
Federica Carloni
Paola Tombesi
Luigi Lazzari-Agli

Background: To assess the efficacy and safety of bevacizumab-containing regimens in the treatment of advanced, chemotherapy-naive, non-squamous non-small cell lung cancer (NSCLC) on

Keywords:

Number needed to harm
Pathology
Bevacizumab
Evidence-based practice
Number needed to treat
Cell
Squamous non-small cell lung cancer
Side effect
Oncology
Medicine
Lung cancer
Internal medicine
non small cell
palliative chemotherapy
non squamous

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations